Web Analysis for Bms-Onkologie - bms-onkologie.de
It is a domain having de extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, bms-onkologie.de is SAFE to browse.
PageSpeed Score
Siteadvisor Rating
Traffic Report
Daily Unique Visitors: | Not Applicable |
Daily Pageviews: | Not Applicable |
Estimated Valuation
Income Per Day: | $ 0.15 |
Estimated Worth: | $ 8.95 |
Search Engine Indexes
Google Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
Google Backlinks: | Not Applicable |
Bing Backlinks: | 679 |
Safety Information
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | No Risk Issues |
WOT Trustworthiness: | Not Applicable |
WOT Child Safety: | Not Applicable |
Website Ranks & Scores
Alexa Rank: | Not Applicable |
Domain Authority: | Not Applicable |
Web Server Information
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
H1 Headings: | 4 | H2 Headings: | 4 |
H3 Headings: | 18 | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 10 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Websites Hosted on Same IP (i.e. 198.155.184.133)
Bristol-Myers Squibb (BMS) - entreprise biopharmaceutique d’envergure
Découvrez Bristol-Myers Squibb et sa mission visant à découvrir, développer et fournir des médicaments innovants qui aident les patients à vaincre des maladies graves.
Bristol-Myers Squibb - 跨国生物制药公司
深入了解Bristol-Myers Squibb以及我们的使命——探索、研发创新性药物,并将它交给患有重大疾病的患者。
BMS HEALTHCARE:医療関係者向け情報サイト
「BMS HEALTHCARE」はブリストル・マイヤーズ スクイブ株式会社が提供する医療関係者向け情報サイトです。
ORENCIA® (abatacept) | Official Patient Site
ORENCIA® (abatacept) is a prescription medication for moderate to severe Adult Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Adult Psoriatic Arthritis. Please see Indication and Important Safety Information.
YERVOY®(ipilimumab) | Consumer | Gateway
YERVOY is a prescription medicine used in adults and children 12 years of age and older to treat melanoma. See Indication, Important Safety Information, and Boxed Warning.
HTTP Header Analysis
Date: Wed, 26 Feb 2020 14:24:31 GMT
Cache-Control: no-cache,must-revalidate,max-age=0,no-store,private
X-Powered-By: Salesforce.com ApexPages
P3P: CP="CUR OTR STA"
Content-Language: en-US
Expires: Thu, 01 Jan 1970 00:00:00 GMT
X-XSS-Protection: 0
X-FRAME-OPTIONS: SAMEORIGIN
Content-Type: text/html;charset=UTF-8
Vary: Accept-Encoding
Content-Encoding: gzip
Connection: close
Domain Nameserver Information
DNS Record Analysis
Host | Type | TTL | Extra |
---|---|---|---|
bms-onkologie.de | A | 597 |
IP: 198.155.184.133 |
bms-onkologie.de | NS | 86400 |
Target: ns3.bms.com |
bms-onkologie.de | NS | 86400 |
Target: ns4.bms.com |
bms-onkologie.de | NS | 86400 |
Target: ns1.bms.com |
bms-onkologie.de | NS | 86400 |
Target: ns2.bms.com |
bms-onkologie.de | SOA | 600 |
MNAME: ns1.bms.com RNAME: dnsadmin.bms.com Serial: 2011111411 Refresh: 10800 Retry: 3600 Expire: 604800 Minimum TTL: 600 |
bms-onkologie.de | MX | 86400 |
Priority: 10 Target: server6.freeline.eu |
Full WHOIS Lookup
%
% Terms and Conditions of Use
%
% The above data may only be used within the scope of technical or
% administrative necessities of Internet operation or to remedy legal
% problems.
% The use for other purposes, in particular for advertising, is not permitted.
%
% The DENIC whois service on port 43 doesn't disclose any information concerning
% the domain holder, general request and abuse contact.
% This information can be obtained through use of our web-based whois service
% available at the DENIC website:
% http://www.denic.de/en/domains/whois-service/web-whois.html
%
%
Domain: bms-onkologie.de
Nserver: ns1.bms.com
Nserver: ns2.bms.com
Nserver: ns3.bms.com
Nserver: ns4.bms.com
Status: connect
Changed: 2019-06-25T19:21:22+02:00